Wird geladen...
Anti-infective monoclonal antibodies: perils and promise of development
So far, most monoclonal antibodies have been developed for treating cancer or immunological diseases. However, the global spread of infections such as West Nile and corona viruses, and the need to address the potential threat of bioterrorism, has boosted public interest in, and government support of...
Gespeichert in:
| Veröffentlicht in: | Nat Rev Drug Discov |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2006
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7097328/ https://ncbi.nlm.nih.gov/pubmed/16518372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd1987 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|